# NALMEFENE HYDROCHLORIDE
> **ANDA216007** · Abbreviated New Drug Application (Generic) · Sponsor: CHENGDU SHUODE · Approved 2023-11-15
## Drug
- **FDA Application Number:** ANDA216007
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALMEFENE HYDROCHLORIDE
- **Generic name:** NALMEFENE HYDROCHLORIDE INJECTION
- **Active ingredients:** NALMEFENE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CHENGDU SHUODE
- **Manufacturer:** Chengdu Shuode Pharmaceutical Co., Ltd
- **First approval:** 2023-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216007)
---
*AI Analytics · CC0 1.0*